9.1.7 Drugs used in other blood disorders - South & West

All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.

Switch to N&E website

Formulary

Back

9.1 Anaemias and some other blood disorders Toggle Pages

9.1.1 Iron-deficiency anaemias 9.1.2 Drugs used in megaloblastic anaemias 9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias 9.1.4 Drugs used in platelet disorders 9.1.6 Drugs used in neutropenia 9.1.7 Drugs used in other blood disorders

Chapter 9: Blood and nutrition Toggle Parent Pages

Management of adult malnutrition Specialist infant formulas in primary care Management of Vitamin D deficiency Neural tube defects (prevention in pregnancy) Prescribing medicines in renal impairment Vitamin and mineral supplements following bariatric surgery 9.1 Anaemias and some other blood disorders 9.2 Fluid and electrolytes 9.3 Intravenous nutrition 9.4 Oral nutrition 9.5 Minerals 9.6 Vitamins 9.8 Metabolic disorders

Print this page

Contact us about this page

9.1.7 Drugs used in other blood disorders

First Line

Second Line

Specialist

Hospital Only

Etranacogene dezaparvovec

Solution for infusion vials 100 tera genome copies/10ml

Notes

NICE TA989: Etranacogene dezaparvovec (Hemgenix) is recommended with managed access as an option for treating moderately severe or severe haemophilia B (congenital factor IX [FIX] deficiency) in adults without anti-FIX antibodies, only if the conditions in the managed access agreement for etranacogene dezaparvovec are followed (July 2024).